Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Frontera Group Inc
OTC:FRTG
|
US |
|
Kukje Pharma Co Ltd
KRX:002720
|
KR |
|
Mitrabara Adiperdana Tbk PT
IDX:MBAP
|
ID |
|
Edreams Odigeo SA
F:K0I
|
ES |
|
A
|
Addnode Group AB (publ)
STO:ANOD B
|
SE |
|
Human Associates Holdings Inc
TSE:6575
|
JP |
|
B
|
Bewith Inc
TSE:9216
|
JP |
|
S
|
Song Da No 9 JSC
VN:SD9
|
VN |
|
Milkyway Chemical Supply Chain Service Co Ltd
SSE:603713
|
CN |
|
B
|
Broad Enterprise Co Ltd
TSE:4415
|
JP |
|
N
|
Noble Metal Group Inc
OTC:NBMLF
|
CA |
Cumberland Pharmaceuticals Inc
Other
Cumberland Pharmaceuticals Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Other
$3.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other
-$260m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
16%
|
CAGR 10-Years
-16%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other
-$128m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-30%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other
-$459m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other
-$131m
|
CAGR 3-Years
18%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other
-$772m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-31%
|
|
Cumberland Pharmaceuticals Inc
Glance View
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. The company is headquartered in Nashville, Tennessee and currently employs 83 full-time employees. The company went IPO on 2009-08-11. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.
See Also
What is Cumberland Pharmaceuticals Inc's Other?
Other
3.6m
USD
Based on the financial report for Dec 31, 2025, Cumberland Pharmaceuticals Inc's Other amounts to 3.6m USD.
